Back to Home

News & Updates

Latest Updates

Stay up to date with C12.ai's latest developments, partnerships, and milestones.

2026.03

Waves (暗涌Waves)

C12.ai Closes ¥50M Round as Robots Effectively Enter the Laboratory

C12.ai completes a new ¥50M funding round led by Yonghua Capital. Its flagship product Talos has been running continuously for 50 days inside BeOne Medicines' lab, performing over 3,000 physical operations with zero execution errors — demonstrating proficiency on par with senior medicinal chemists.

Read Original Article

2026.03

VB Data (动脉网)

C12.ai Raises ¥50M to Accelerate Physical AI Scientist Deployment, Begins Live Testing at BeOne Medicines Lab

C12.ai completes a ¥50M funding round. Its flagship product Talos has been running continuously for 50 days inside BeOne Medicines' pharmaceutical lab, performing over 3,000 physical operations with zero execution errors.

Read Original Article

2026.03

Yunqi Partners (云启资本)

The 'OpenAI Moment' for Pharma Labs: C12.ai Raises ¥50M as Robot Scientists Step onto the Lab Bench

Inside BeOne Medicines' lab, C12.ai's robot system Talos has been running for 50 days, completing over 3,000 experiment operations with zero errors. C12.ai closes a new ¥50M round led by Yonghua Capital, bringing AI from the digital world into real laboratories.

Read Original Article

2025.08

Huxiu

Anti-Cancer Drug R&D Finally Hits the Fast-Forward Button

Humanity has never stopped fighting diseases like cancer, Alzheimer's, and AIDS. But hampered by the slow pace of new drug development, this battle has long awaited a qualitative breakthrough. The emergence of generative AI-powered large models is now fundamentally changing this trajectory.

Read Original Article

2025.03

C12.ai

AI Robots Enter the Laboratory

How can artificial intelligence deeply integrate with physical laboratories to achieve exponential leaps in research efficiency? C12.ai's laboratory solutions power intelligent upgrades in pharmaceutical R&D, serving the life sciences and fine chemicals industries with LabBot — an AI robot that truly understands the lab.

Read Original Article

2024.07

C12.ai

Exploring the Future of Pharmaceutical R&D

LabBot — the industry's first intelligent pharmaceutical R&D robot, developed by C12.ai, combines an AI-powered pharmaceutical brain with embodied intelligence. It autonomously designs and executes experiments, analyzes results, and continuously learns from expert feedback and experimental outcomes.

Read Original Article